Replies to post #13907 on Pluristem Therapeutics Inc (PSTI)

[zzaatt]

You are spot on recognizing that competition is of significant concern.

No, he's not! I'll be concerned when the competition comes up with something even close to PLX-R18 in its broad support of reconstituting all cells lines after any kind of radiation damage. Only PLX-R18 can do that!

The only competition to PLX-PAD in CLI is revasc. surgery, not much of a competing therapy.

It's all about the POTENTIAL!!